Global Influenza Vaccine Market & Forecast By (Pediatrics & Adult) & Vaccine Brands Analysis 2011-2022

Dublin, May 22, 2017 -- Research and Markets has announced the addition of the "Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis" report to their offering.

Global Influenza Vaccine Market is worth more than US$ 5 Billion

Global Influenza Vaccine Market & Forecast (30 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis is our 8th report on the Influenza Vaccine Market. This is a 383 page report with 386 Figures and 7 Tables provides data of 30 countries globally on Influenza Vaccine Market. The report provides data on Pediatrics and Adult Influenza Vaccinated Population Numbers and Market.

Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period.

United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine Market Share was almost 4 times more than China and Japan Influenza Vaccine Market Share. United States & China together captures close to 60 percent in Pediatrics Influenza Vaccine Market Share. Whereas, in adult vaccination segments, United States and Japan will share more than 50 percent market share by 2022.

Scope of Study:

- Influenza Vaccine Market has been divided into two segments Pediatrics Influenza Vaccine Market and Adult Influenza Vaccine Market
- Influenza Vaccine Market share & Forecast, Pediatrics Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast
- Influenza Vaccinated Population & Forecast has been divided into two segments Pediatrics Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast
- Influenza Vaccine Brand Sales and Forecast

All 30 Countries have been extensively studied from 2 major points, which has been further sub-divided into 2 more points:

1. Influenza Vaccine Market & Forecast (2011 - 2022)
a. Pediatrics Influenza Vaccine Market & Forecast
b. Adult Influenza Vaccine Market & Forecast

2. Influenza Vaccinated Population & Forecast (2011 - 2022)
a. Pediatrics Influenza Vaccinated Population & Forecast
b. Adult Influenza Vaccinated Population & Forecast

This report offers the best viewpoint on the leading five influenza vaccine brands:
1. Vaxigrip/Fluzone
2. Fluarix/ Flulaval
3. FluMist/Fluenz
4. Afluria/Fluvax and Fluvirin/Flucelvax
5. Anflu

This report is a combination of 6 reports:
1. Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis
2. Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast
3. Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)
4. Nordics Seasonal Influenza Vaccine Market Forecast in (Denmark, Finland, Iceland, Norway & Sweden) By (Child & Adult) Vaccination
5. Seasonal Influenza Vaccination Market in Hungary, Romania, Slovakia and Slovenia (East Europe) By (Infant & Adult) Forecast
6. Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast

Key Topics Covered:

1 Executive Summary

2 Influenza - Introduction

3 Structure of Influenza Virus

4 Notable Influenza Pandemics

5 Worldwide Influenza Vaccinated Population

6 Worldwide Seasonal Influenza Vaccine Market

7 Worldwide Seasonal Influenza Vaccine Market Share Analysis

8 United States

9 Netherlands

10 Denmark

11 Estonia

12 Finland

13 Germany

14 France

15 Hungary

16 Iceland

17 Ireland

18 Italy

19 Latvia

20 Lithuania

21 Luxembourg

22 Malta

23 Norway

24 Poland

25 Portugal

26 Romania

27 Slovakia

28 Slovenia

29 Spain

30 Sweden

31 United Kingdom

32 China

33 India

34 Brazil

35 Japan

36 Australia

37 New Zealand

38 Worldwide - Seasonal Influenza Vaccine Brand Sales and Forecast

39 Seasonal Influenza Vaccine - Growth Drivers

40 Seasonal Influenza Vaccine - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/5tq8d8/global_influenza

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Vaccines, Pediatrics